Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival

Summit Sawhney; Aldo J Montano-Loza; Peter Salat; Mairin McCarthy; Norman Kneteman; Judith Meza-Junco; Richard Owen

doi:10.1155/2011/864234

Canadian Journal of Gastroenterology (Jan 2011)

Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Predictors of Survival

Summit Sawhney,
Aldo J Montano-Loza,
Peter Salat,
Mairin McCarthy,
Norman Kneteman,
Judith Meza-Junco,
Richard Owen

Affiliations

Summit Sawhney: Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, Canada
Aldo J Montano-Loza: Division of Gastroenterology & Hepatology, University of Alberta Hospital, Canada
Peter Salat: Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, Canada
Mairin McCarthy: Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, Canada
Norman Kneteman: Department of Surgery, University of Alberta Hospital, Canada
Judith Meza-Junco: Department of Medical Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
Richard Owen: Department of Radiology and Diagnostic Imaging, University of Alberta Hospital, Canada

DOI: https://doi.org/10.1155/2011/864234
Journal volume & issue: Vol. 25, no. 8
pp. 426 – 432

Abstract

Read online

BACKGROUND: Transarterial chemoembolization (TACE) is the mainstay of management for patients with hepatocellular carcinoma who are not suitable for curative treatments.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal